dc.creator | Martins, CVB | |
dc.creator | de Resende, MA | |
dc.creator | Magalhaes, TFF | |
dc.creator | Lima, BHS | |
dc.creator | Watanabe, GA | |
dc.creator | Ruiz, ALTG | |
dc.creator | de Carvalho, JE | |
dc.creator | Pilli, RA | |
dc.creator | de Fatima, A | |
dc.date | 2008 | |
dc.date | JAN | |
dc.date | 2014-11-15T19:52:06Z | |
dc.date | 2015-11-26T17:21:43Z | |
dc.date | 2014-11-15T19:52:06Z | |
dc.date | 2015-11-26T17:21:43Z | |
dc.date.accessioned | 2018-03-29T00:09:12Z | |
dc.date.available | 2018-03-29T00:09:12Z | |
dc.identifier | Letters In Drug Design & Discovery. Bentham Science Publ Ltd, v. 5, n. 1, n. 74, n. 78, 2008. | |
dc.identifier | 1570-1808 | |
dc.identifier | WOS:000254078800014 | |
dc.identifier | http://www.repositorio.unicamp.br/jspui/handle/REPOSIP/77675 | |
dc.identifier | http://www.repositorio.unicamp.br/handle/REPOSIP/77675 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/77675 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1283433 | |
dc.description | A large number of human diseases are caused by fungus and the plant kingdom has proven to be a source of antifungal compounds. This work describes the in vitro activity of the natural product (R)-goniothalamin and its synthetic enantiomer, (S)-goniothalamin, against eleven strains of human pathogenic fungi. The minimum inhibitory concentration (MIC) values for both enantiomers were lower than 100 mu g/mL for nine of the fungus strains studied. MIC values for both enantiomers against isolates of the dimorphic fungus Paracoccidioides braziliensis were in the range of 7-22 mu g/mL. (R)- and (S)-goniothalamin were selective for the fungi strains presenting minimal toxic effects on mammalian kidney (Vero) and lung (V79) cell lines. | |
dc.description | 5 | |
dc.description | 1 | |
dc.description | 74 | |
dc.description | 78 | |
dc.language | en | |
dc.publisher | Bentham Science Publ Ltd | |
dc.publisher | Sharjah | |
dc.publisher | Emirados Árabes Unidos | |
dc.relation | Letters In Drug Design & Discovery | |
dc.relation | Lett. Drug Des. Discov. | |
dc.rights | fechado | |
dc.source | Web of Science | |
dc.subject | fungi infections | |
dc.subject | Goniothalamus | |
dc.subject | goniothalamin | |
dc.subject | antifungal agents | |
dc.subject | minimum inhibitory concentration | |
dc.subject | antiproliferative activity | |
dc.subject | Fungal-infections | |
dc.subject | Transplant Recipients | |
dc.subject | Cytotoxic Activity | |
dc.subject | Natural-products | |
dc.subject | Styryl-lactones | |
dc.subject | Cell Lines | |
dc.subject | Drugs | |
dc.subject | Derivatives | |
dc.subject | Discovery | |
dc.subject | Fungemia | |
dc.title | Antifungal activity of goniothalamin enantiomers | |
dc.type | Artículos de revistas | |